Showing 1 - 14 results of 14 for search 'Vincenzo Spagnuolo', query time: 0.04s
Refine Results
-
1
-
2
Levels of soluble endothelial protein C receptor are associated with CD4+ changes in Maraviroc-treated HIV-infected patients. by Silvia Nozza, Manuela Pogliaghi, Stefania Chiappetta, Vincenzo Spagnuolo, Gessica Fontana, Cristina Razzari, Giuseppe Tambussi, Elena Maria Faioni
Published 2012-01-01
Article -
3
Association between low levels of HIV-1 DNA and HLA class I molecules in chronic HIV-1 infection. by Camilla Muccini, Monica Guffanti, Vincenzo Spagnuolo, Massimo Cernuschi, Laura Galli, Alba Bigoloni, Andrea Galli, Andrea Poli, Sara Racca, Antonella Castagna
Published 2022-01-01
Article -
4
Disseminated Mycobacterium chimaera infection favoring the development of Kaposi’s sarcoma: a case report by Tommaso Clemente, Vincenzo Spagnuolo, Martina Bottanelli, Marco Ripa, Benedetto Del Forno, Elena Busnardo, Giuseppe Di Lucca, Antonella Castagna, Anna Danise
Published 2022-12-01
Article -
5
Association between low levels of HIV-1 DNA and HLA class I molecules in chronic HIV-1 infection by Camilla Muccini, Monica Guffanti, Vincenzo Spagnuolo, Massimo Cernuschi, Laura Galli, Alba Bigoloni, Andrea Galli, Andrea Poli, Sara Racca, Antonella Castagna
Published 2022-01-01
Article -
6
Durability of switch regimens based on rilpivirine or on integrase inhibitors, both in association with tenofovir and emtricitabine, in HIV-infected, virologically suppressed patie... by Nicola Gianotti, Andrea Poli, Silvia Nozza, Laura Galli, Nadia Galizzi, Marco Ripa, Marco Merli, Alessia Carbone, Vincenzo Spagnuolo, Adriano Lazzarin, Antonella Castagna
Published 2017-11-01
Article -
7
Immune response to hepatitis B vaccination in HIV-positive individuals with isolated antibodies against hepatitis B core antigen: Results of a prospective Italian study. by Giulia Morsica, Sabrina Bagaglio, Vincenzo Spagnuolo, Antonella Castagna, Clelia Di Serio, Andrea Galli, Liviana Della Torre, Andrea Andolina, Alexander Pramov, Caterina Uberti-Foppa
Published 2017-01-01
Article -
8
Increasing incidence and prevalence of metabolic syndrome in people living with HIV during the COVID-19 pandemic by Rebecka Papaioannu Borjesson, Laura Galli, Camilla Muccini, Andrea Poli, Tommaso Clemente, Martina Bottanelli, Nicola Gianotti, Silvia Nozza, Silvia Nozza, Antonella Castagna, Antonella Castagna, Vincenzo Spagnuolo
Published 2023-09-01
Article -
9
Efficacy and safety of switching from branded to generic antiretrovirals in virologically suppressed HIV-infected patients. by Nicola Gianotti, Andrea Poli, Laura Galli, Michela Franzin, Patrizia Tadini, Nadia Galizzi, Alessia Carbone, Marco Merli, Camilla Muccini, Chiara Oltolini, Andrea Andolina, Vincenzo Spagnuolo, Adriano Lazzarin, Antonella Castagna
Published 2017-01-01
Article -
10
Impact of Analytical Treatment Interruption on Burden and Diversification of HIV Peripheral Reservoir: A Pilot Study by Rossana Scutari, Valentino Costabile, Laura Galli, Maria Concetta Bellocchi, Luca Carioti, Silvia Barbaliscia, Andrea Poli, Andrea Galli, Carlo Federico Perno, Maria Mercedes Santoro, Antonella Castagna, Francesca Ceccherini-Silberstein, Claudia Alteri, Vincenzo Spagnuolo
Published 2021-07-01
Article -
11
Heavily treatment-experienced persons living with HIV currently in care in Italy: characteristics, risk factors, and therapeutic options—the ICONA Foundation cohort study by Sergio Lo Caputo, Mariacristina Poliseno, Alessandro Tavelli, Roberta Gagliardini, Stefano Rusconi, Giuseppe Lapadula, Andrea Antinori, Daniela Francisci, Loredana Sarmati, Andrea Gori, Vincenzo Spagnuolo, Francesca Ceccherini-Silberstein, Antonella d'Arminio Monforte, Alessandro Cozzi-Lepri
Published 2024-06-01
Article -
12
Refining criteria for selecting candidates for a safe lopinavir/ritonavir or darunavir/ritonavir monotherapy in HIV-infected virologically suppressed patients. by Nicola Gianotti, Alessandro Cozzi-Lepri, Andrea Antinori, Antonella Castagna, Andrea De Luca, Benedetto Maurizio Celesia, Massimo Galli, Cristina Mussini, Carmela Pinnetti, Vincenzo Spagnuolo, Antonella d'Arminio Monforte, Francesca Ceccherini-Silberstein, Massimo Andreoni, Icona Foundation Study and mono-PI/r database Study Cohorts
Published 2017-01-01
Article -
13
Cohort profile: PRESTIGIO, an Italian prospective registry-based cohort of people with HIV-1 resistant to reverse transcriptase, protease and integrase inhibitors by Roberta Gagliardini, Maria Mercedes Santoro, Filippo Lagi, Stefano Rusconi, Antonella Castagna, Emanuele Focà, Antonio Di Biagio, Micol Ferrara, Franco Maggiolo, Giulia Marchetti, Laura Galli, Vincenzo Spagnuolo, Riccardo Lolatto, Tommaso Clemente, Anna Maria Cattelan, Adriana Cervo, Leonardo Calza, Giovanni Cenderello, Maurizio Zazzi
Published 2024-02-01
Article -
14
Virologic and immunologic outcomes of treatment with integrase inhibitors in a real-world setting: The RESPOND cohort consortium. by Bastian Neesgaard, Amanda Mocroft, Robert Zangerle, Ferdinand Wit, Fiona Lampe, Huldrych F Günthard, Coca Necsoi, Matthew Law, Cristina Mussini, Antonella Castagna, Antonella d'Arminio Monforte, Christian Pradier, Nikoloz Chkhartisvilli, Juliana Reyes-Uruena, Jörg Janne Vehreschild, Jan-Christian Wasmuth, Anders Sönnerborg, Christoph Stephan, Lauren Greenberg, Josep M Llibre, Alain Volny-Anne, Lars Peters, Annegret Pelchen-Matthews, Vani Vannappagari, Joel Gallant, Armin Rieger, Mike Youle, Dominique Braun, Stephane De Wit, Kathy Petoumenos, Vanni Borghi, Vincenzo Spagnuolo, Tengiz Tsertsvadze, Jens Lundgren, Lene Ryom, RESPOND study group
Published 2020-01-01
Article